Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 1451-1500 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06771336
Biomedical Innovation for Facial Bone Reconstruction in Oncology: BIOFACE PASS a Medico-economic Study Describing the Standard Pathway of Patients Treated by Free Bone Flap
N/ARecruiting
200 participants
Started: Sep 3, 2025 · Completed: Dec 31, 2029
1 condition1 sponsor9 locations
NCT07183228
Eatit's Obesity Intervention: Effects on Weight, Eating Habits and Health
NARecruiting
93 participants
Started: Sep 3, 2025 · Completed: Aug 1, 2026
2 conditions3 sponsors1 location
NCT07110610
Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy Participants
PHASE1Recruiting
220 participants
Started: Sep 3, 2025 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06593379
Mobile Intervention for Suicidal Thoughts
NARecruiting
50 participants
Started: Sep 3, 2025 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT07005362
Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D
N/ARecruiting
36 participants
Started: Sep 3, 2025 · Completed: Dec 31, 2025
7 conditions2 sponsors1 location
NCT07059078
Brief Motivational Interviewing +/- Mindfulness Training for Adolescent Alcohol Use in Pediatric Primary Care
NARecruiting
1,500 participants
Started: Sep 3, 2025 · Completed: Sep 30, 2030
1 condition2 sponsors13 locations
NCT06731452
Exploring Neurophysiological Markers of Brain Health
NARecruiting
63 participants
Started: Sep 3, 2025 · Completed: May 31, 2027
2 conditions1 sponsor1 location
NCT07061288
A Study to Evaluate the Dose Levels, Safety, and Drug Levels of Single KarXT Intramuscular Injection in Participants With Schizophrenia
PHASE1Recruiting
48 participants
Started: Sep 3, 2025 · Completed: Oct 15, 2027
1 condition1 sponsor8 locations
NCT06915454
High-Resolution PET-CT Imaging for Surgical Margin Visualization
NARecruiting
50 participants
Started: Sep 3, 2025 · Completed: Jul 31, 2027
5 conditions3 sponsors1 location
NCT07094932
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBD09
PHASE1Recruiting
36 participants
Started: Sep 3, 2025 · Completed: Dec 13, 2025
1 condition1 sponsor1 location
NCT06907667
Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure
NARecruiting
735 participants
Started: Sep 3, 2025 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT07155057
Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery
NARecruiting
60 participants
Started: Sep 3, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT07176988
Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes
NARecruiting
120 participants
Started: Sep 3, 2025 · Completed: Apr 30, 2029
2 conditions2 sponsors1 location
NCT07204652
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
N/ARecruiting
20 participants
Started: Sep 3, 2025 · Completed: Sep 30, 2029
4 conditions2 sponsors1 location
NCT06626438
Treatable Traits in Interstitial Lung Disease
NARecruiting
110 participants
Started: Sep 3, 2025 · Completed: Jul 31, 2027
1 condition3 sponsors2 locations
NCT07156773
The Study is Being Conducted to Evaluate the Safety and Efficacy of XJN010 Nasal Spray in Patients With Parkinson's Disease Experiencing Off Episodes
PHASE2Recruiting
84 participants
Started: Sep 3, 2025 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT07211269
Individual Differences in Cognitive Control Predict Real-time fMRI Neurofeedback Performance
NARecruiting
40 participants
Started: Sep 3, 2025 · Completed: Jan 12, 2026
1 condition1 sponsor1 location
NCT06919354
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
PHASE1Recruiting
16 participants
Started: Sep 3, 2025 · Completed: Feb 29, 2028
2 conditions1 sponsor9 locations
NCT06930651
A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies
PHASE1/PHASE2Recruiting
42 participants
Started: Sep 3, 2025 · Completed: May 1, 2030
1 condition1 sponsor1 location
NCT07069374
Wellness, Intervention Strategies and HIV Care
NARecruiting
50 participants
Started: Sep 3, 2025 · Completed: Mar 30, 2026
2 conditions2 sponsors2 locations
NCT07003997
JAK Signaling in Depression
PHASE2Recruiting
100 participants
Started: Sep 3, 2025 · Completed: Feb 28, 2030
1 condition2 sponsors1 location
NCT06592820
Endoscopic Ultrasound Shear Wave Elastography Study
N/ARecruiting
300 participants
Started: Sep 3, 2025 · Completed: Mar 28, 2027
4 conditions1 sponsor2 locations
NCT07151391
The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)
PHASE2Recruiting
86 participants
Started: Sep 3, 2025 · Completed: Sep 30, 2028
2 conditions1 sponsor1 location
NCT07166614
Dexmedetomidine vs Propofol in High-Risk ERCP Patients
NARecruiting
2 participants
Started: Sep 3, 2025 · Completed: Jan 15, 2026
4 conditions1 sponsor1 location
NCT07214883
UCF MammoChat: Image Repository
N/ARecruiting
20,000 participants
Started: Sep 3, 2025 · Completed: Jun 30, 2026
6 conditions2 sponsors1 location
NCT07152249
Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial
NARecruiting
13,120 participants
Started: Sep 3, 2025 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT07025044
Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections
N/ARecruiting
40 participants
Started: Sep 3, 2025 · Completed: Jun 1, 2026
2 conditions2 sponsors1 location
NCT06985862
Development of Artificial Intelligence Tools for the Detection of Stress Markers and Consideration of Stress States in the Monitoring of Subjects With Type 1 Diabetes
NARecruiting
35 participants
Started: Sep 3, 2025 · Completed: Feb 28, 2026
1 condition1 sponsor2 locations
NCT07071350
Randomized Controlled Trial of Treatment to Optimize Heart Rate Variability for Persistent Post-Concussion Symptoms
PHASE2/PHASE3Recruiting
148 participants
Started: Sep 2, 2025 · Completed: Sep 30, 2028
5 conditions2 sponsors1 location
NCT07178665
Pilot Trial of Preop Partial Radiation in Breast Cancer Patients
PHASE1Recruiting
98 participants
Started: Sep 2, 2025 · Completed: Jun 1, 2028
3 conditions1 sponsor10 locations
NCT06761196
Quality of Life After Breast Cancer Surgery
N/ARecruiting
1,500 participants
Started: Sep 2, 2025 · Completed: Sep 1, 2035
2 conditions1 sponsor1 location
NCT06893783
Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients
PHASE2Recruiting
60 participants
Started: Sep 2, 2025 · Completed: Apr 30, 2029
3 conditions4 sponsors4 locations
NCT07159347
Assessment of Daily Stressors in Children With Depressive Symptoms for the Development of a Gamified Emotion Regulation App
N/ARecruiting
15 participants
Started: Sep 2, 2025 · Completed: Dec 31, 2026
3 conditions8 sponsors1 location
NCT06960083
Transcranial Magnetic Stimulation in Misophonia
NARecruiting
60 participants
Started: Sep 2, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06638151
Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime)
PHASE2Recruiting
200 participants
Started: Sep 2, 2025 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT07059325
Accelerated TMS for Seizure-Type Functional Neurologic Disorders
EARLY_PHASE1Recruiting
30 participants
Started: Sep 2, 2025 · Completed: Jul 1, 2027
2 conditions1 sponsor1 location
NCT06821568
Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome
NARecruiting
128 participants
Started: Sep 2, 2025 · Completed: Jun 30, 2029
3 conditions3 sponsors2 locations
NCT06980688
The PROTECT Trial: PROpofol Titration to Enhance haemodynamiC sTability
NARecruiting
320 participants
Started: Sep 2, 2025 · Completed: Sep 30, 2027
1 condition3 sponsors4 locations
NCT07061613
Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Venous Leg Ulcers
NARecruiting
10 participants
Started: Sep 2, 2025 · Completed: Mar 29, 2026
1 condition2 sponsors1 location
NCT07059234
The Motor Activity - Subjective Energy (MASE) Project
NARecruiting
180 participants
Started: Sep 2, 2025 · Completed: Apr 30, 2027
1 condition6 sponsors1 location
NCT07174661
Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors
NARecruiting
50 participants
Started: Sep 2, 2025 · Completed: Jun 30, 2027
3 conditions1 sponsor1 location
NCT06984627
A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
PHASE2Recruiting
30 participants
Started: Sep 2, 2025 · Completed: Sep 23, 2026
1 condition1 sponsor12 locations
NCT06999603
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
PHASE2Recruiting
550 participants
Started: Sep 2, 2025 · Completed: May 31, 2027
1 condition1 sponsor23 locations
NCT07112443
A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia.
PHASE3Recruiting
12 participants
Started: Sep 2, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT07140770
Sleep and Physical Activity in Patient and Caregiver Dyads Following Allogeneic Hematopoietic Cell Transplantation
N/ARecruiting
66 participants
Started: Sep 2, 2025 · Completed: Apr 1, 2028
3 conditions1 sponsor1 location
NCT07039617
AIDANET At Home Study
NARecruiting
40 participants
Started: Sep 2, 2025 · Completed: Jul 31, 2026
1 condition4 sponsors1 location
NCT07060365
A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combination Therapy in Participants With Advanced/Recurrent Ovarian Cancer
PHASE1/PHASE2Recruiting
30 participants
Started: Sep 2, 2025 · Completed: May 29, 2029
1 condition2 sponsors23 locations
NCT07157774
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
PHASE3Recruiting
10,450 participants
Started: Sep 2, 2025 · Completed: Mar 31, 2031
2 conditions1 sponsor662 locations
NCT07147634
Outdoor Science Education and Child Well-being in Primary Schools: Protocol for a Cluster Randomized Controlled Trial on Learning, Connection to Nature, Eco-anxiety, and Stress
NARecruiting
1,000 participants
Started: Sep 2, 2025 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT07093814
A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
PHASE1/PHASE2Recruiting
42 participants
Started: Sep 2, 2025 · Completed: Jun 30, 2029
1 condition1 sponsor1 location